Richard Ley, spokesman for the Association of the British Pharmaceutical Industry, said there was a growing trend to move trials to cheaper countries.

“Companies are looking to eastern Europe for clinical trials, where the science is excellent and costs are much lower,” he said.

Fees charged by the doctors and NHS institutions reportedly make the UK one...